GLP-1 receptors in the brain are heterogeneous and may exert different effects depending on the region and second messenger pathways involved, suggesting the existence of different functional subtypes
Retatrutide has not yet received marketing authorisation from the MHRA or the EMA, and therefore no official UK or European prescribing guidelines currently exist for this agent
If you experience severe abdominal pain, particularly if it radiates to your back and is accompanied by nausea and vomiting, this could indicate pancreatitis and requires immediate medical attention via your GP, NHS 111, or 999 in severe cases
Supplementary Figure 1 demonstrates the changes in YFAS for each participant
How do PT-141 and Melanotan 2 differ pharmacokinetically
Neurological manifestations include developmental delay, psychomotor retardation, behavioral abnormalities, ataxia, peripheral neuropathy, and seizures